Do you consider resuming Venetoclax for patients with CLL upon progression/recurrence, in whom Venetoclax/Rituximab achieved CR and Venetoclax was previously well tolerated but stopped after completing 2 years of therapy?  

Yes, in such situations in clinical practice, retrying venetoclax is entirely appropriate. How long has the patient been off prior exposure to venetoclax is a factor to consider, more than 2 years would make me more apt to retry venetoclax. Whether the patient has been given BTKi in the past and h...